Michael M Meagher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael M Meagher

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Gene Therapy|January 8, 2022

Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cellsYoung-In Kim-Hoehamer, Janice M Riberdy, Fei Zheng, et al.

Clinical and Vaccine Immunology : CVI|January 2, 2015

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old childrenElisabeth Adderson, Kristen Branum, Robert E Sealy, et al.

Cancer Discovery|July 6, 2022

Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor LineagesTaylor L Wilson, Hyunjin Kim, Ching-Heng Chou, et al.

Science Advances|October 6, 2023

Integrome signatures of lentiviral gene therapy for SCID-X1 patientsKoon-Kiu Yan, Jose Condori, Zhijun Ma, et al.

The New England Journal of Medicine|April 18, 2019

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, et al.

Blood Advances|April 21, 2022

Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Gene Therapy|January 8, 2022

Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cellsYoung-In Kim-Hoehamer, Janice M Riberdy, Fei Zheng, et al.

Clinical and Vaccine Immunology : CVI|January 2, 2015

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old childrenElisabeth Adderson, Kristen Branum, Robert E Sealy, et al.

Cancer Discovery|July 6, 2022

Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor LineagesTaylor L Wilson, Hyunjin Kim, Ching-Heng Chou, et al.

Science Advances|October 6, 2023

Integrome signatures of lentiviral gene therapy for SCID-X1 patientsKoon-Kiu Yan, Jose Condori, Zhijun Ma, et al.

The New England Journal of Medicine|April 18, 2019

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, et al.

Blood Advances|April 21, 2022

Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.

Pageof 4